Search Results - "Chen, David Y.T"

Anatomic Features of Enhancing Renal Masses Predict Malignant and High-Grade Pathology: A Preoperative Nomogram Using the RENAL Nephrometry Score by Kutikov, Alexander, Smaldone, Marc C, Egleston, Brian L, Manley, Brandon J, Canter, Daniel J, Simhan, Jay, Boorjian, Stephen A, Viterbo, Rosalia, Chen, David Y.T, Greenberg, Richard E, Uzzo, Robert G

“…Abstract Background Counseling patients with enhancing renal mass currently occurs in the context of significant uncertainty regarding tumor pathology…”
Get full text

Growth kinetics and short-term outcomes of cT1b and cT2 renal masses under active surveillance by Mehrazin, Reza, Smaldone, Marc C, Kutikov, Alexander, Li, Tianyu, Tomaszewski, Jeffrey J, Canter, Daniel J, Viterbo, Rosalia, Greenberg, Richard E, Chen, David Y T, Uzzo, Robert G

“…Compared to T1a lesions the natural history of untreated renal masses larger than 4 cm is poorly understood. We assessed the growth kinetics and outcomes of…”
Get more information

Robot-assisted Partial Nephrectomy: A Large Single-institutional Experience by Scoll, Benjamin J, Uzzo, Robert G, Chen, David Y.T, Boorjian, Stephen A, Kutikov, Alexander, Manley, Brandon J, Viterbo, Rosalia

“…Objectives To report experience with 100 robot-assisted partial nephrectomy (RAPN) operations performed at our institution. Nephron-sparing surgery is an…”
Get full text

Perioperative outcomes of robotic and open partial nephrectomy for moderately and highly complex renal lesions by Simhan, Jay, Smaldone, Marc C, Tsai, Kevin J, Li, Tianyu, Reyes, Jose M, Canter, Daniel, Kutikov, Alexander, Chen, David Y T, Greenberg, Richard E, Uzzo, Robert G, Viterbo, Rosalia

“…We compared outcomes in patients undergoing robotic vs open partial nephrectomy stratified by moderately and highly complex tumor nephrometry scores. Patients…”
Get more information

Coexisting hybrid malignancy in a solitary sporadic solid benign renal mass: implications for treating patients following renal biopsy by Ginzburg, Serge, Uzzo, Robert, Al-Saleem, Tahseen, Dulaimi, Essel, Walton, John, Corcoran, Anthony, Plimack, Elizabeth, Mehrazin, Reza, Tomaszewski, Jeffrey, Viterbo, Rosalia, Chen, David Y T, Greenberg, Richard, Smaldone, Marc, Kutikov, Alexander

“…Concern regarding coexisting malignant pathology in benign renal tumors deters renal biopsy and questions its validity. We examined the rates of coexisting…”
Get more information

Baseline Renal Function Status Limits Patient Eligibility to Receive Perioperative Chemotherapy for Invasive Bladder Cancer and Is Minimally Affected by Radical Cystectomy by Canter, Daniel, Viterbo, Rosalia, Kutikov, Alexander, Wong, Yu-Ning, Plimack, Elizabeth, Zhu, Fang, Oblaczynski, Megan, Berberian, Raffi, Chen, David Y.T, Greenberg, Richard E, Uzzo, Robert G, Boorjian, Stephen A

“…Objectives To evaluate the proportion of patients with muscle-invasive urothelial carcinoma (UC) who would be eligible to receive cisplatin-based chemotherapy…”
Get full text

Does Treatment Duration Affect Outcome After Radiotherapy for Prostate Cancer? by D'Ambrosio, David J., M.D, Li, Tianyu, M.S, Horwitz, Eric M., M.D, Chen, David Y.T., M.D, Pollack, Alan, M.D., Ph.D, Buyyounouski, Mark K., M.D., M.S

“…Purpose The protraction of external beam radiotherapy (RT) time is detrimental in several disease sites. In prostate cancer, the overall treatment time can be…”
Get full text

Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer by Plimack, Elizabeth R, Dunbrack, Roland L, Brennan, Timothy A, Andrake, Mark D, Zhou, Yan, Serebriiskii, Ilya G, Slifker, Michael, Alpaugh, Katherine, Dulaimi, Essel, Palma, Norma, Hoffman-Censits, Jean, Bilusic, Marijo, Wong, Yu-Ning, Kutikov, Alexander, Viterbo, Rosalia, Greenberg, Richard E, Chen, David Y.T, Lallas, Costas D, Trabulsi, Edouard J, Yelensky, Roman, McConkey, David J, Miller, Vincent A, Golemis, Erica A, Ross, Eric A

“…Abstract Background Cisplatin-based neoadjuvant chemotherapy (NAC) before cystectomy is the standard of care for muscle-invasive bladder cancer (MIBC), with…”
Get full text

Active Surveillance for Localized Renal Masses: Tumor Growth, Delayed Intervention Rates, and >5-yr Clinical Outcomes by McIntosh, Andrew G., Ristau, Benjamin T., Ruth, Karen, Jennings, Rachel, Ross, Eric, Smaldone, Marc C., Chen, David Y.T., Viterbo, Rosalia, Greenberg, Richard E., Kutikov, Alexander, Uzzo, Robert G.

“…Active surveillance (AS) has gained acceptance as a management strategy for localized renal masses. To review our large single-center experience with AS. From…”
Get full text

Objective Measures of Renal Mass Anatomic Complexity Predict Rates of Major Complications Following Partial Nephrectomy by Simhan, Jay, Smaldone, Marc C, Tsai, Kevin J, Canter, Daniel J, Li, Tianyu, Kutikov, Alexander, Viterbo, Rosalia, Chen, David Y.T, Greenberg, Richard E, Uzzo, Robert G

“…Abstract Background The association between tumor complexity and postoperative complications after partial nephrectomy (PN) has not been well characterized…”
Get full text

A Phase II Study of Pazopanib in Patients with Localized Renal Cell Carcinoma to Optimize Preservation of Renal Parenchyma by Rini, Brian I, Plimack, Elizabeth R, Takagi, Toshio, Elson, Paul, Wood, Laura S, Dreicer, Robert, Gilligan, Timothy, Garcia, Jorge, Zhang, Zhiling, Kaouk, Jihad, Krishnamurthi, Venkatesh, Stephenson, Andrew J, Fergany, Amr, Klein, Eric A, Uzzo, Robert G, Chen, David Y.T, Campbell, Steven C

“…Purpose Preservation of renal function is prioritized during surgical management of localized renal cell carcinoma. VEGF targeted agents can downsize tumors in…”
Get full text

Residual Parenchymal Volume, Not Warm Ischemia Time, Predicts Ultimate Renal Functional Outcomes in Patients Undergoing Partial Nephrectomy by Ginzburg, Serge, Uzzo, Robert, Walton, John, Miller, Christopher, Kurz, David, Li, Tianyu, Handorf, Elizabeth, Gor, Ronak, Corcoran, Anthony, Viterbo, Rosalia, Chen, David Y.T, Greenberg, Richard E, Smaldone, Marc C, Kutikov, Alexander

“…Objective To examine relative contributions of functional parenchymal preservation and renal ischemia following nephron-sparing surgery (NSS). While residual…”
Get full text

The natural history of observed enhancing renal masses: meta-analysis and review of the world literature by Chawla, Sam N, Crispen, Paul L, Hanlon, Alexandra L, Greenberg, Richard E, Chen, David Y T, Uzzo, Robert G

“…Standard therapy for an enhancing renal mass is surgical. However, operative treatment may not be plausible in all clinical circumstances. Data on the natural…”
Get more information

Utility of the R.E.N.A.L. Nephrometry Scoring System in Objectifying Treatment Decision-making of the Enhancing Renal Mass by Canter, Daniel, Kutikov, Alexander, Manley, Brandon, Egleston, Brian, Simhan, Jay, Smaldone, Marc, Teper, Ervin, Viterbo, Rosalia, Chen, David Y.T, Greenberg, Richard E, Uzzo, Robert G

“…Objective To evaluate the treatment patterns of solid renal masses according to the quantifiable anatomic features using nephrometry. The treatment of…”
Get full text

Enhancing renal masses with zero net growth during active surveillance by Kunkle, David A, Crispen, Paul L, Chen, David Y T, Greenberg, Richard E, Uzzo, Robert G

“…The natural history of small renal masses is generally to slowly increase in size. However, a subset of lesions does not show radiographic growth. We compared…”
Get more information

Assessing the Burden of Complications After Surgery for Clinically Localized Kidney Cancer by Age and Comorbidity Status by Tomaszewski, Jeffrey J, Uzzo, Robert G, Kutikov, Alexander, Hrebinko, Katie, Mehrazin, Reza, Corcoran, Anthony, Ginzburg, Serge, Viterbo, Rosalia, Chen, David Y.T, Greenberg, Richard E, Smaldone, Marc C

“…Objective To examine the association between high-risk patient status (age >75 years or Charlson comorbidity index count >2) and postoperative complications in…”
Get full text

Care transitions between hospitals are associated with treatment delay for patients with muscle invasive bladder cancer by Tomaszewski, Jeffrey J, Handorf, Elizabeth, Corcoran, Anthony T, Wong, Yu-Ning, Mehrazin, Reza, Bekelman, Justin E, Canter, Daniel, Kutikov, Alexander, Chen, David Y T, Uzzo, Robert G, Smaldone, Marc C

“…Hypothesizing that changing hospitals between diagnosis and definitive therapy (care transition) may delay timely treatment, we identified the association…”
Get more information

Perioperative outcomes following partial nephrectomy performed on patients remaining on antiplatelet therapy by Ito, Timothy, Derweesh, Ithaar H, Ginzburg, Serge, Abbosh, Philip H, Raheem, Omer A, Mirheydar, Hossein, Hamilton, Zachary, Chen, David Y.T, Smaldone, Marc C, Greenberg, Richard E, Viterbo, Rosalia, Kutikov, Alexander, Uzzo, Robert G

“…Abstract Objective We evaluated the risk of bleeding complications in patients undergoing partial nephrectomy (PN) in whom perioperative anti-platelet (AP)…”
Get full text

Genomic Copy Number Alterations in Renal Cell Carcinoma with Sarcomatoid Features by Ito, Timothy, Pei, Jianming, Dulaimi, Essel, Menges, Craig, Abbosh, Philip H, Smaldone, Marc C, Chen, David Y.T, Greenberg, Richard E, Kutikov, Alexander, Viterbo, Rosalia, Uzzo, Robert G, Testa, Joseph R

“…Purpose Sarcomatoid changes in renal cell carcinoma are associated with a poor prognosis. The identification of genetic alterations that drive this…”
Get full text

Anatomic Complexity Quantitated by Nephrometry Score Is Associated With Prolonged Warm Ischemia Time During Robotic Partial Nephrectomy by Tomaszewski, Jeffrey J, Smaldone, Marc C, Mehrazin, Reza, Kocher, Neil, Ito, Timothy, Abbosh, Philip, Baber, Jacob, Kutikov, Alexander, Viterbo, Rosalia, Chen, David Y.T, Canter, Daniel J, Uzzo, Robert G

“…Objective To assess the association between nephrometry score (NS) and prolonged warm ischemia time (WIT) in patients undergoing robotic partial nephrectomy…”
Get full text